ClinicalTrials.Veeva

Menu

Sexual Dysfunction Check-up in Premenopausal Breast Cancer Survivors Taking Endocrine Therapy: A Cross-Sectional Study (SEXCHECK)

C

Candiolo Cancer Institute - IRCCS

Status

Enrolling

Conditions

Breast Cancer Female
Sexual Dysfunction
Premenopausal Breast Cancer

Treatments

Other: Questionnaire

Study type

Observational

Funder types

Other

Identifiers

NCT06458764
71/2023

Details and patient eligibility

About

Primary objectives:

  • To estimate Sexual Dysfunction (SD) incidence in premenopausal breast cancer patients treated by surgery and taking endocrine therapy.
  • To detect the presence of SD-related distress in the population, as a determining factor in the maintenance of a good quality of life.

Secondary objectives:

  • To describe SD characteristics determining the most frequently reported symptoms and correlations with type of surgery or therapeutic regimens.
  • Collect baseline data for subsequent randomized trials involving practical interventions with the aim to reduce SD prevalence in this population.

Enrollment

150 estimated patients

Sex

Female

Ages

18 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • women aged ≥18 and ≤ 55
  • who underwent surgery for early stage breast cancer
  • taking endocrine therapy for at least 3 months
  • providing an informed consent and completing the study questionnaires.

Exclusion criteria

  • withdrawal of the informed consent, at any time

Trial design

150 participants in 2 patient groups

Patients
Treatment:
Other: Questionnaire
Controls
Treatment:
Other: Questionnaire

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems